⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer
globenewswire.com
RVMD
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
globenewswire.com
RADX
Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
globenewswire.com
BNTC
COCO ROBOTICS AND DELIVEROO ANNOUNCE EXCLUSIVE PARTNERSHIP TO SCALE ROBOT DELIVERIES ACROSS THE UK
prnewswire.com
DASH
Manulife Announces Presenting Partnership of The Hinton Lectures™ on AI Safety
prnewswire.com
MFC
Dooap Brings Agentic AI for Accounts Payable to Community Summit North America 2026
prnewswire.com
MSFT
GDRTA Selects ConnXAI to Deliver Unified Customer Communications Platform Powered by ConnXAI Maestro™
prnewswire.com
AI
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
globenewswire.com
PMVP
Magnite to Announce Third Quarter 2026 Financial Results on November 4, 2026
globenewswire.com
MGNI
Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
globenewswire.com
LLY